Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-03-27

FDA Approved: SELZENTRY — Supplemental Application (ViiV Healthcare Company)

View source ↗

Summary

FDA approved a supplemental application for Selzentry (maraviroc) submitted by ViiV Healthcare Company. The approval updates the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Selzentry (Maraviroc)

Snippet

SUPPL AP for SELZENTRY (MARAVIROC)